Grupo de Estudos Vasculares, Porto, Portugal.
Centro de Acessos Vasculares Nephrocare Gaia, Porto, Portugal.
Blood Purif. 2018;46(2):94-102. doi: 10.1159/000488442. Epub 2018 Apr 19.
The definition of significant stenosis (SS) remains controversial.
We retrospectively reviewed 1,040 consultations. SS was defined in the presence of clinical and echo-Doppler (DDU) criteria: Qa <500 mL/min or Qa decrease >25%; RI >0.7 in the feeding artery or absolute minimal luminal stenosis diameter <2.0 mm. Stenosis without any additional criteria were considered borderline stenosis (BS).
Two hundred twenty-one arteriovenous fistulas (AVFs) were included: 58.8% had SS, 18.6% had BS, and 22.6% had no dysfunctional access (ND). SS had a significantly higher thrombotic events than BS and ND (13.1 vs. 4.4%, p = 0.018). The annual thrombosis rate was 0.007, 0.037, and 0.004 in the ND, SS, and BS, respectively. AVF cumulative survival at 5 years was significantly lower in SS (89.5%) compared to BS (100%) and ND (97.4%; p = 0.03). BS had an HR for AVF failure of 1.1, p = 0.955, while the SS presented an HR of 5.9, p = 0.09.
AVF clinical monitoring with additional DDU criteria appear to be appropriate for therapeutic referral.
狭窄程度的定义仍存在争议。
我们回顾性分析了 1040 例会诊。狭窄程度定义为存在临床和超声多普勒(DDU)标准:Qa <500 mL/min 或 Qa 下降>25%;供血动脉 RI >0.7 或绝对最小管腔狭窄直径 <2.0 mm。没有其他标准的狭窄程度被认为是临界狭窄(BS)。
221 例动静脉瘘(AVF)中,58.8%存在 SS,18.6%存在 BS,22.6%不存在功能障碍性通路(ND)。SS 的血栓形成事件发生率明显高于 BS 和 ND(13.1%比 4.4%,p = 0.018)。ND、SS 和 BS 的年血栓形成率分别为 0.007、0.037 和 0.004。SS 的 AVF 累积 5 年生存率明显低于 BS(89.5%比 100%和 ND(97.4%;p = 0.03)。BS 的 AVF 失败风险比(HR)为 1.1,p = 0.955,而 SS 的 HR 为 5.9,p = 0.09。
AVF 临床监测结合额外的 DDU 标准似乎适合进行治疗转诊。